نتایج جستجو برای: iranian companies

تعداد نتایج: 118575  

2015
Shari Paige Elaine Hatfield Lu Liang

Recent political events in the United States have created a political climate that promotes prejudice against Middle Eastern, Iranian, and Muslim people. In this study, we were interested in investigating two questions: (1) How welcome do Iranian-American men and women from various religious backgrounds (Muslim, Jewish, or no religious affiliation) feel in their new homeland (specifically, how ...

2017
Ali Janati Homayoun Sadeghi-bazargani Edris Hasanpoor Mobin Sokhanvar Elaheh HaghGoshyie

Ali Janati, Homayoun Sadeghi-bazargani, Edris Hasanpoor, Mobin Sokhanvar, Elaheh HaghGoshyie. Associate professor, PhD of Healthcare Management, Iranian Center of Excellence in Health Management (IceHM), Tabriz University of Medical Sciences, Tabriz, Iran; Professor, PhD of Epidemiology, Road Traffic Injury Prevention Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; PhD can...

2017
Morteza Arab-Zozani Habib Jalilian Mina Mahami Oskouei Mohammad Dehghanian Zoleikha Asadi Aghbalaghi

IRAN: A STAKEHOLDER ANALYSIS Morteza Arab-Zozani, Habib Jalilian, Mina Mahami Oskouei, Mohammad Dehghanian, Zoleikha Asadi Aghbalaghi. School of management and medical informatics, Iranian Center of Excellence in Health Management, Tabriz University of Medical Sciences, Tabriz, Iran; School of management and medical informatics, Iranian Center of Excellence in Health Management, Tabriz Universi...

2015
Qianren Zhou Kun Huang Di Huang QIANREN ZHOU

Sales forecasting is a common topic in business. Our task is predicting a famous drug company daily sales for 1,115 stores located across Germany for six weeks in advance. Store sales are influenced by many factors. Our project aims to create a robust prediction model. Based on Gradient Boosting and Random Forest, our model performs well in this sales forecasting competition with resulting in r...

1965
H. Merskey

In November, 1963, a small private symposium met at Johns Hopkins Univers^ to explore what were the major problems in making safe and effective drugs avails. from both the academic and industrial fields were present. In addition, the gt?f. included economists, the president of a drug company, lawyers and an Eng'1^ social scientist (Professor Richard Titmuss). In the course of their deliberation...

Journal: :Lancet 2008
Stephen MacMahon Michael H Alderman Lars H Lindholm Lisheng Liu Ramiro A Sanchez Yackoob K Seedat

I n global-health politics, cardiovascular disease is the elephant in the room—a massive problem that few want to acknowledge and even fewer want to tackle. In [a recent issue of] Lancet, Carlene Lawes and colleagues, on behalf of the International Society of Hypertension, estimate that bloodpressure-related diseases cause about half this burden, killing around 8 million people each year.1 Low-...

Journal: :Health affairs 2011
Maran Wolston

without prior written permission from the Publisher. All rights reserved. or mechanical, including photocopying or by information storage or retrieval systems, may be reproduced, displayed, or transmitted in any form or by any means, electronic States copyright law (Title 17, U.S. Code), no part of by Project HOPE The People-to-People Health Foundation. As provided by United Suite 600, Bethesda...

2001
Michael Geraghty

Highlights Q The Good: Sweeping reform plan does not pass because it is too costly to be financed without huge taxes. But, healthcare disinflation continues; drug companies keep their pricing increases to CPI or CPI + 1%. Health supply/device stocks unit growth flattens, but best companies still achieve 12-15% growth. Firms withdraw from marginal businesses, trim sales forces/product lines and ...

Journal: :The Los Angeles times 2003
David Willman

Dr. Salk's professional life was as far removed from that oftoday's researchers at the National Institutes ofHealth as the sun is from, say, Wall Street. Theoretically, the NIH belongs to the American people. U.S. taxpayers give it $28 billion a year to develop remedies for human misery. Many assume that today's NIH researchers are carrying on the mission as Salk did, free from financial or com...

Journal: :Journal of thrombosis and haemostasis : JTH 2006
B L Evatt

The Occasional Papers series is intended to provide a forum for examining a wide range of topics of interest to the hemophilia community. The World Federation of Hemophilia does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. Dose schedules and other treatment regimes are continually revised and new side effects recogni...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید